Pacific Biosciences of California, Inc. (PACB) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
PACB Historical Performance
Short-Term Returns
PACB Stock Price Trajectory (2011–2026)
As of May 8, 2026, Pacific Biosciences of California, Inc. (PACB) trades at $1.65, representing a +46.0% return over the past year. The stock has delivered a -93.4% total return over five years (-41.9% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $53.69 on February 11, 2021. From this peak, PACB has corrected -96.9%, currently trading 2% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ILMN (+81.7% 1Y), BFLY (+94.5% 1Y), and CDNA (+45.2% 1Y), PACB has underperformed the peer group average. Compare PACB vs ILMN →
PACB Historical Price Data (2025–2026)
Showing 30 of 3,650 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.70 | 1.76 | 1.63 | 1.65 | 6.06M | -3.51% |
| 2026-05-06 | 1.60 | 1.73 | 1.58 | 1.71 | 7.06M | +8.23% |
| 2026-05-05 | 1.55 | 1.58 | 1.50 | 1.58 | 5.77M | +1.94% |
| 2026-05-04 | 1.57 | 1.62 | 1.53 | 1.55 | 3.60M | -3.13% |
| 2026-05-01 | 1.59 | 1.62 | 1.53 | 1.60 | 4.97M | +0.63% |
| 2026-04-30 | 1.48 | 1.60 | 1.48 | 1.59 | 4.96M | +8.16% |
| 2026-04-29 | 1.55 | 1.56 | 1.42 | 1.47 | 5.88M | -6.96% |
| 2026-04-28 | 1.56 | 1.58 | 1.53 | 1.58 | 3.97M | -0.63% |
| 2026-04-27 | 1.54 | 1.68 | 1.53 | 1.59 | 7.08M | +1.92% |
| 2026-04-24 | 1.55 | 1.63 | 1.51 | 1.56 | 11.02M | -1.27% |
| 2026-04-23 | 1.68 | 1.69 | 1.55 | 1.58 | 9.65M | -7.60% |
| 2026-04-22 | 1.76 | 1.77 | 1.67 | 1.71 | 4.71M | -0.58% |
| 2026-04-21 | 1.74 | 1.80 | 1.67 | 1.72 | 7.92M | -1.15% |
| 2026-04-20 | 1.65 | 1.75 | 1.64 | 1.74 | 4.15M | +2.96% |
| 2026-04-17 | 1.70 | 1.75 | 1.66 | 1.69 | 8.35M | +3.68% |
| 2026-04-16 | 1.63 | 1.65 | 1.54 | 1.63 | 5.34M | +1.87% |
| 2026-04-15 | 1.52 | 1.64 | 1.52 | 1.60 | 4.31M | +1.98% |
| 2026-04-14 | 1.49 | 1.59 | 1.47 | 1.57 | 6.24M | +8.21% |
| 2026-04-13 | 1.33 | 1.46 | 1.33 | 1.45 | 4.75M | +8.21% |
| 2026-04-10 | 1.36 | 1.38 | 1.31 | 1.34 | 3.54M | -0.74% |
| 2026-04-09 | 1.46 | 1.47 | 1.35 | 1.35 | 5.44M | -8.16% |
| 2026-04-08 | 1.56 | 1.59 | 1.43 | 1.47 | 5.23M | +2.08% |
| 2026-04-07 | 1.39 | 1.47 | 1.36 | 1.44 | 4.23M | +1.41% |
| 2026-04-06 | 1.34 | 1.45 | 1.33 | 1.42 | 6.33M | +5.97% |
| 2026-04-02 | 1.30 | 1.36 | 1.28 | 1.34 | 6.47M | -0.74% |
| 2026-04-01 | 1.36 | 1.40 | 1.34 | 1.35 | 8.17M | +2.27% |
| 2026-03-31 | 1.27 | 1.34 | 1.27 | 1.32 | 9.57M | +4.76% |
| 2026-03-30 | 1.26 | 1.27 | 1.24 | 1.26 | 9.37M | 0.00% |
| 2026-03-27 | 1.35 | 1.35 | 1.23 | 1.26 | 8.64M | -6.67% |
| 2026-03-26 | 1.37 | 1.40 | 1.33 | 1.35 | 4.64M | -2.88% |
See PACB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PACB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PACB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPACB — Frequently Asked Questions
Quick answers to the most common questions about buying PACB stock.
How has PACB stock performed recently?
PACB returned +46.0% over the past year, beating its 5-year annualized CAGR of -41.9%. The stock trades below its 200-day moving average, confirming the uptrend.
What is PACB's all-time high price?
Pacific Biosciences of California, Inc. reached $53.69 on 2021-02-11. The 52-week high is $2.73. Current 1-year return of +46.0% places the stock closer to historical peaks.
Where can I download PACB historical price data?
This page provides PACB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.